474 related articles for article (PubMed ID: 29890027)
1. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
3. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
5. Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.
Ma Q; Dieterich LC; Ikenberg K; Bachmann SB; Mangana J; Proulx ST; Amann VC; Levesque MP; Dummer R; Baluk P; McDonald DM; Detmar M
Sci Adv; 2018 Aug; 4(8):eaat4758. PubMed ID: 30101193
[TBL] [Abstract][Full Text] [Related]
6. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
7. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
9. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
11. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
13. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
14. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.
Lv XH; Liu BQ; Li XM; Wang XC; Li XL; Ahmed N; Zhang YF
Anat Rec (Hoboken); 2016 Jun; 299(6):741-7. PubMed ID: 26917449
[TBL] [Abstract][Full Text] [Related]
15. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
[No Abstract] [Full Text] [Related]
16. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
[TBL] [Abstract][Full Text] [Related]
17. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
[TBL] [Abstract][Full Text] [Related]
18. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
Front Immunol; 2018; 9():412. PubMed ID: 29599774
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
